methylphenidate has been researched along with Acquired Immunodeficiency Syndrome in 4 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Excerpt | Relevance | Reference |
---|---|---|
"Seven patients with AIDS-related cognitive and emotional deficits had neuropsychologic testing and then were treated with methylphenidate or dextroamphetamine in individualized doses." | 2.67 | Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. ( Angrist, B; d'Hollosy, M; Diamond, G; Sanfilipo, M; Satriano, J; Simberkoff, M; Weinreb, H, 1992) |
"Bereavement after diagnosing AIDS or other HIV disease, psychological symptoms secondary to brain disease and the social consequences of having AIDS all interact to produce a devastating illness where the patient may be intensely grieving, demented and totally rejected by all of society." | 1.27 | Psychosocial aspects of AIDS. ( Goldmeier, D, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angrist, B | 1 |
d'Hollosy, M | 1 |
Sanfilipo, M | 1 |
Satriano, J | 1 |
Diamond, G | 1 |
Simberkoff, M | 1 |
Weinreb, H | 1 |
Walling, VR | 1 |
Pfefferbaum, B | 1 |
Fernandez, F | 1 |
Levy, JK | 1 |
Galizzi, H | 1 |
Goldmeier, D | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy (KAP) for Patients at End of Life-A Pilot Study for Palliative and Hospice Care[NCT05214417] | Phase 2 | 120 participants (Anticipated) | Interventional | 2022-05-01 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for methylphenidate and Acquired Immunodeficiency Syndrome
Article | Year |
---|---|
Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dextroamphetamine; Humans; Male; Mental Disorders; Methyl | 1992 |
3 other studies available for methylphenidate and Acquired Immunodeficiency Syndrome
Article | Year |
---|---|
The use of methylphenidate in a depressed adolescent with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Child Abuse; Depressive Disorder; Dose-Response Rela | 1990 |
Response of HIV-related depression to psychostimulants: case reports.
Topics: Acquired Immunodeficiency Syndrome; Adult; Depressive Disorder; Dextroamphetamine; Humans; Male; Met | 1988 |
Psychosocial aspects of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Attitude to Health; Brain Diseases; Child; Dementia; Dextroamphe | 1987 |